Sofie Van Gijsel: Welcome all to the audio webcast of Galapagos Q1 2024 Results. I m Sofie Van Gijsel, Investor Relations representing the reporting team at Galapagos.
Operator: Good morning and welcome to the Fulcrum Therapeutics First Quarter 2023 Financial Results and Business Update Conference Call. Currently all participants are in a listen-only mode.
Operator: Good day, and thank you for standing by. Welcome to the Acumen Pharma Q1 2023 Conference Call and Webcast. At this time all participants are in a listen-only mode.